[23, 24] This silencing of TFPI2 through promoter cytosine–phosphorothioate–guanine methylation has been widely reported to be associated with elevated cancer cell invasion and progression in many types of cancers including breast cancers and gliomas [25]. The gene discussed is TFPI2; the disease is breast cancer.